Impact of age, gender, and race on circulating γδ T cells

Human Immunology

Volumn 71, Issue 10, 2010, Pages 968-975

  Cairo, Cristiana ^a   Armstrong, Cheryl L ^a   Cummings, Jean Saville ^a   Deetz, Carl O ^a   Tan, Ming ^a   Lu, Changwan ^a   Davis, Charles E ^a   Pauza, C David ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

GammaDelta; Human; Racial identity; T cell

Indexed keywords

CD27 ANTIGEN; CD45RA ANTIGEN; CD56 ANTIGEN; GRANZYME B; T LYMPHOCYTE RECEPTOR;

AFRICAN AMERICAN; AGE; ARTICLE; CAUCASIAN; CELL POPULATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENDER; HUMAN; HUMAN EXPERIMENT; INFECTION; MULTIVARIATE ANALYSIS; NEOPLASM; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE; T LYMPHOCYTE;

ADULT; AFRICAN AMERICANS; AGE FACTORS; CELL COUNT; CELL SEPARATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SEX FACTORS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 77956615949     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.06.014     Document Type: Article

References (49)

1. Hsieh M.M., Everhart J.E., Byrd-Holt D.D., Tisdale J.F., Rodgers G.P. Prevalence of neutropenia in the U.S. population: Age, sex, smoking status, and ethnic differences. Ann Intern Med 2007, 146:486-492.
2. + lymphocyte counts in high-risk immunodeficiency virus (HIV)-seronegative women enrolled in the Women's Interagency HIV Study (WIHS). Hum Immunol 2007, 68:342-349.
3. Haddy T.B., Rana S.R., Castro O. Benign ethnic neutropenia: What is a normal absolute neutrophil count?. J Lab Clin Med 1999, 133:15-22.
4. Hershman D., Weinberg M., Rosner Z., Alexis K., Tiersten A., Grann V.R., et al. Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst 2003, 95:1545-1548.
5. Beagley K.W., Husband A.J. Intraepithelial lymphocytes: Origins, distribution, and function. Crit Rev Immunol 1998, 18:237-254.
6. Groh V., Steinle A., Bauer S., Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998, 279:1737-1740.
7. Dechanet J., Merville P., Lim A., Retiere C., Pitard V., Lafarge X., et al. Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest 1999, 103:1437-1449.
8. Casorati G., De Libero G., Lanzavecchia A., Migone N. Molecular analysis of human gamma/delta+ clones from thymus and peripheral blood. J Exp Med 1989, 170:1521-1535.
9. De Libero G., Casorati G., Giachino C., Carbonara C., Migone N., Matzinger P., Lanzavecchia A. Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells. J Exp Med 1991, 173:1311-1322.
10. Panchamoorthy G., McLean J., Modlin R.L., Morita C.T., Ishikawa S., Brenner M.B., Band H. A predominance of the T cell receptor V gamma 2/V delta 2 subset in human mycobacteria-responsive T cells suggests germline gene encoded recognition. J Immunol 1991, 147:3360-3369.
11. + T cell receptor-alpha/beta-circulating lymphocytes. J Exp Med 1988, 167:694-699.
12. Davodeau F., Peyrat M.A., Hallet M.M., Houde I., Vie H., Bonneville M. Peripheral selection of antigen receptor junctional features in a major human gamma delta subset. Eur J Immunol 1993, 23:804-808.
13. Davodeau F., Peyrat M.A., Hallet M.M., Gaschet J., Houde I., Vivien R., et al. Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors. J Immunol 1993, 151:1214-1223.
14. Tanaka Y., Morita C.T., Tanaka Y., Nieves E., Brenner M.B., Bloom B.R. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 1995, 375:155-158.
15. Jomaa H., Feurle J., Luhs K., Kunzmann V., Tony H.P., Herderich M., Wilhelm M. Vgamma9/Vdelta2 T cell activation induced by bacterial low molecular mass compounds depends on the 1-deoxy-D-xylulose 5-phosphate pathway of isoprenoid biosynthesis. FEMS Immunol Med Microbiol 1999, 25:371-378.
16. Eberl M., Hintz M., Reichenberg A., Kollas A.K., Wiesner J., Jomaa H. Microbial isoprenoid biosynthesis and human gammadelta T cell activation. FEBS Lett 2003, 544:4-10.
17. Morita C.T., Beckman E.M., Bukowski J.F., Tanaka Y., Band H., Bloom B.R., et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 1995, 3:495-507.
18. Parker C.M., Groh V., Band H., Porcelli S.A., Morita C., Fabbi M., et al. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med 1990, 171:1597-1612.
19. Urban E.M., Li H., Armstrong C., Focaccetti C., Cairo C., Pauza C.D. Control of CD56 expression and tumor cell cytotoxicity in human Vgamma2Vdelta2 T cells. BMC Immunol 2009, 10:50.
20. Ho M., Webster H.K., Tongtawe P., Pattanapanyasat K., Weidanz W.P. Increased gamma delta T cells in acute Plasmodium falciparum malaria. Immunol Lett 1990, 25:139-141.
21. Bertotto A., Gerli R., Spinozzi F., Muscat C., Scalise F., Castellucci G., et al. Lymphocytes bearing the gamma delta T cell receptor in acute Brucella melitensis infection. Eur J Immunol 1993, 23:1177-1180.
22. Sumida T., Maeda T., Takahashi H., Yoshida S., Yonaha F., Sakamoto A., et al. Predominant expansion of V gamma. 9/V delta 2 T cells in a tularemia patient. Infect Immun 1992, 60:2554-2558.
23. Poquet Y., Kroca M., Halary F., Stenmark S., Peyrat M.A., Bonneville M., et al. Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect Immun 1998, 66:2107-2114.
24. Balbi B., Valle M.T., Oddera S., Giunti D., Manca F., Rossi G.A., Allegra L. T-lymphocytes with gamma delta+ V delta. 2+ antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidosis. Am Rev Respir Dis 1993, 148:1685-1690.
25. Esin S., Batoni G., Kallenius G., Gaines H., Campa M., Svenson S.B., et al. Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Myco. avium. Clin Exp Immunol 1996, 104:419-425.
26. Ito M., Kojiro N., Ikeda T., Ito T., Funada J., Kokubu T. Increased proportions of peripheral blood gamma delta T cells in patients with pulmonary tuberculosis. Chest 1992, 102:195-197.
27. Sicard H., Ingoure S., Luciani B., Serraz C., Fournie J.J., Bonneville M., et al. In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J Immunol 2005, 175:5471-5480.
28. Cairo C., Hebbeler A.M., Propp N., Bryant J.L., Colizzi V., David Pauza C. Innate-like gammadelta T cell responses to mycobacterium Bacille Calmette-Guerin using the public Vgamma2 repertoire in Macaca fascicularis. Tuberculosis Edinb 2007, 87:373-383.
29. Caccamo N., Dieli F., Wesch D., Jomaa H., Eberl M. Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cells. J Leukoc Biol 2006, 79:663-666.
30. Hviid L., Akanmori B.D., Loizon S., Kurtzhals J.A., Ricke C.H., Lim A., et al. High frequency of circulating gamma delta T cells with dominance of the v(delta)1 subset in a healthy population. Int Immunol 2000, 12:797-805.
31. Li H., Peng H., Ma P., Ruan Y., Su B., Ding X., et al. Association between Vgamma2Vdelta2 T cells and disease progression after infection with closely related strains of HIV in China. Clin Infect Dis 2008, 46:1466-1472.
32. Evans P.S., Enders P.J., Yin C., Ruckwardt T.J., Malkovsky M., Pauza C.D. In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors. Immunology 2001, 104:19-27.
33. Cairo C., Hebbeler A.M., Propp N., Bryant J.L., Colizzi V., Pauza C.D. Innate-like gammadelta T cell responses to mycobacterium Bacille Calmette-Guerin using the public Vgamma2 repertoire in Macaca fascicularis. Tuberculosis Edinb 2007, 87:373-383.
34. Cairo C., Propp N., Auricchio G., Armstrong C.L., Abimiku A., Mancino G., et al. Altered cord blood gammadelta T cell repertoire in Nigeria: Possible impacts of environmental factors on neonatal immunity. Mol Immunol 2008, 45:3190-3197.
35. Bain B., Seed M., Godsland I. Normal values for peripheral blood white cell counts in women of four different ethnic origins. J Clin Pathol 1984, 37:188-193.
36. Freedman D.S., Gates L., Flanders W.D., Van Assendelft O.W., Barboriak J.J., Joesoef M.R., Byers T. Black/white differences in leukocyte subpopulations in men. Int J Epidemiol 1997, 26:757-764.
37. Alexander A.A., Maniar A., Cummings J.S., Hebbeler A.M., Schulze D.H., Gastman B.R., et al. Isopentenyl pyrophosphate-activated CD56+ {gamma} {delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma. Clin Cancer Res 2008, 14:4232-4240.
38. Angelini D.F., Borsellino G., Poupot M., Diamantini A., Poupot R., Bernardi G., et al. FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood 2004, 104:1801-1807.
39. Gioia C., Agrati C., Casetti R., Cairo C., Borsellino G., Battistini L., et al. Lack of CD27-CD45RA-V gamma 9 V delta. 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J Immunol 2002, 168:1484-1489.
40. Cummings J.S., Cairo C., Armstrong C., Davis C.E., Pauza C.D. Impacts of HIV infection on V{gamma}2V{delta}2 T cell phenotype and function: A mechanism for reduced tumor immunity in AIDS. J Leukoc Biol 2008, 84:371-379.
41. Poccia F., Battistini L., Cipriani B., Mancino G., Martini F., Gougeon M.L., Colizzi V. Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J Infect Dis 1999, 180:858-861.
42. Lang F., Peyrat M.A., Constant P., Davodeau F., David-Ameline J., Poquet Y., et al. Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J Immunol 1995, 154:5986-5994.
43. Christmas S.E., Meager A. Production of interferon-gamma and tumour necrosis factor-alpha by human T-cell clones expressing different forms of the gamma delta receptor. Immunology 1990, 71:486-492.
44. Fisch P., Malkovsky M., Braakman E., Sturm E., Bolhuis R.L., Prieve A., et al. Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis. J Exp Med 1990, 171:1567-1579.
45. De Rosa S.C., Andrus J.P., Perfetto S.P., Mantovani J.J., Herzenberg L.A., Herzenberg L.A., Roederer M. Ontogeny of gamma delta T cells in humans. J Immunol 2004, 172:1637-1645.
46. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci U S A 1998, 95:5690-5693.
47. Lantz O., Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific;CD4+ and CD4-8- T cells in mice and humans. J Exp Med 1994, 180:1097-1106.
48. Hebbeler A.M., Cairo C., Cummings J.S., Pauza C.D. Individual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: Generating tumor effectors with low molecular weight phosphoantigens. Cancer Immunol Immunother 2007, 56:819-829.
49. Hebbeler A.M., Propp N., Cairo C., Li H., Cummings J.S., Jacobson L.P., et al. Failure to restore the Vgamma2-Jgamma1.2 repertoire in HIV-infected men receiving highly active antiretroviral therapy (HAART). Clin Immunol 2008, 128:349-357.